With 2024 coming to a close and 2025 starting to take shape, the healthcare and pharmaceutical sectors appear set to build on the positive momentum accumulated in the last year. The seismic developments that characterized 2024 have emboldened these s...
Shantanu has more than a decade
of experience in diverse practice areas of general corporate, corporate
restructuring, mergers and acquisitions and private equity investments. He has
been representing multinational companies in various cross-border transactions,
advising on foreign direct investments, outbound investments, joint ventures,
technology transfers as well as commercial contracting issues.
Shantanu’s work experience also
includes advising Indian and foreign clients on private equity investments in
India and on various issues arising out of the exchange control laws, Companies
Act and sector specific laws.
He has special interest in the
healthcare and life sciences sectors and has assisted clients in some of the
very prominent deals in the past.
Shantanu has written on a variety
of subjects including exchange control laws and legal developments in the
healthcare sector for the print and electronic media.
Prior to joining INDUSLAW,
Shantanu was a partner at JSA.
publications
All publications
All publications